cached image

Joseph R. Bertino, M.D.

Affiliations: 
Weill Cornell Medical College, New York, NY, United States 
 1961-1987 Yale University School of Medicine, New Haven, CT 
Area:
Biochemistry, Molecular Biology, Pharmacology
Website:
http://www.aacr.org/Membership/Pages/FellowDetailsNoModal.aspx?ItemID=5#.WthR-kxuLDc
Google:
"Joseph Bertino"
Bio:

https://www.bcrf.org/researchers/joseph-r-bertino

Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rather GM, Anyanwu M, Kerrigan JE, et al. (2019) Abstract 5213: A modified L-penetratin peptide targeting e2f-1, 2 and 3 is effective in combination with cisplatin or pemetrexed against prostate and lung cancer cell lines Cancer Research. 79: 5213-5213
Shaik T, Rather GM, Bansal N, et al. (2018) Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer. Oncotarget. 9: 33249-33257
Kimani SG, Kumar S, Bansal N, et al. (2017) Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity. Scientific Reports. 7: 43908
Tedeschi PM, Bansal N, Kerrigan JE, et al. (2016) NAD+ Kinase as a Therapeutic Target in Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Bansal N, Bartucci M, Yusuff S, et al. (2016) BMI-1 targeting interferes with patient-derived tumor-initiating cell survival and tumor growth in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Tedeschi PM, Scotto KW, Kerrigan J, et al. (2016) MTHFD2- a new twist? Oncotarget. 7: 7368-9
Tedeschi PM, Scotto KW, Kerrigan J, et al. (2016) MTHFD2-a new twist? Oncotarget. 7: 7368-7369
Tedeschi PM, Lin H, Gounder M, et al. (2015) Suppression of Cytosolic NADPH Pool by Thionicotinamide Increases Oxidative Stress and Synergizes with Chemotherapy. Molecular Pharmacology. 88: 720-7
Tedeschi PM, Vazquez A, Kerrigan JE, et al. (2015) Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development. Molecular Cancer Research : McR. 13: 1361-6
Bansal N, Mishra PJ, Stein M, et al. (2015) Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells. Oncotarget
See more...